TY - JOUR
T1 - Predictors of low bone density and fracture risk in Loeys–Dietz syndrome
AU - Guerrerio, Anthony L.
AU - Mateja, Allyson
AU - Rasooly, Marjohn
AU - Levin, Samara
AU - Magnani, Alaina
AU - Dempsey, Caeden
AU - MacCarrick, Gretchen
AU - Dietz, Harry C.
AU - Brittain, Erica
AU - Boyce, Alison M.
AU - Frischmeyer-Guerrerio, Pamela A.
N1 - Funding Information:
This project was funded in whole or in part by the Division of Intramural Research, National Institute of Allergy and Infectious Disease and the National Institute of Dental and Craniofacial Research, National Institutes of Health , the Loeys–Dietz Syndrome Foundation , and with federal funds from the National Cancer Institute, National Institutes of Health , under contract number 75N910D00024, task order number 75N91019F00130. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government. Research reported in this publication was supported by the Howard Hughes Medical Institute , the William S. Smilow Center for Marfan Syndrome Research, the Kasper Precision Medicine Center of Excellence for Genetic Syndromes and Aortopathies, and the Johns Hopkins inHealth strategic initiative to advance precision medicine at Johns Hopkins.
Funding Information:
This project was funded in whole or in part by the Division of Intramural Research, National Institute of Allergy and Infectious Disease and the National Institute of Dental and Craniofacial Research, National Institutes of Health, the Loeys?Dietz Syndrome Foundation, and with federal funds from the National Cancer Institute, National Institutes of Health, under contract number 75N910D00024, task order number 75N91019F00130. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government. Research reported in this publication was supported by the Howard Hughes Medical Institute, the William S. Smilow Center for Marfan Syndrome Research, the Kasper Precision Medicine Center of Excellence for Genetic Syndromes and Aortopathies, and the Johns Hopkins inHealth strategic initiative to advance precision medicine at Johns Hopkins. Conceptualization: A.L.G. A.M.B. P.A.F-G.; Data Curation: M.R. S.L. A.Mag. C.D.; Formal Analysis: A.Mat. E.B.; Methodology: A.L.G. A.Mat. E.B. A.M.B. P.A.F-G.; Resources: G.M. H.C.D. A.M.B. P.A.F-G.; Supervision: A.M.B. P.A.F-G.; Visualization: A.Mat. E.B.; Writing-original draft: A.L.G. A.Mat. P.A.F-G.; Writing-review and editing: A.L.G. A.Mat. G.M. H.C.D. E.B. A.M.B. P.A.F-G. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the National Institutes of Health's institutional review board. Informed consent was obtained from all participants. Patients/guardians have consented to publication in writing.
Publisher Copyright:
© 2021
PY - 2022/2
Y1 - 2022/2
N2 - Purpose: Loeys–Dietz syndrome (LDS) is a connective tissue disorder affecting multiple organ systems, including bone. Methods: We defined the bone phenotype and clinical predictors of low bone density and fracture risk in 77 patients with LDS type 1 to type 5. Results: Patients with LDS had dual-energy x-ray absorptiometry (DXA) Z-scores significantly < 0, and 50% of children and 9% of adults had Z-scores < –2. Sixty percent of patients had ≥1 fracture, and 24% of patients with spinal x-rays scans showed spinal compression fractures. Lower body mass index, asthma, male sex and eosinophilic gastrointestinal disease were correlated with lower DXA Z-scores. The count of 5 LDS-associated skeletal features (scoliosis, pes planus, arachnodactyly, spondylolisthesis, and camptodactyly) in patients with LDS was correlated with DXA Z-score. Adults with ≥1 skeletal features had DXA Z-scores significantly < 0, and children with >2 features had DXA Z-score significantly < –2. Bone turnover markers suggest accelerated bone resorption. Data from 5 patients treated with bisphosphonates suggest a beneficial effect. Conclusion: All LDS types are associated with reduced bone density and increased risk of fracture, which may be due to increased bone resorption. Clinical features can predict a subgroup of patients at highest risk of low bone density and fracture risk.
AB - Purpose: Loeys–Dietz syndrome (LDS) is a connective tissue disorder affecting multiple organ systems, including bone. Methods: We defined the bone phenotype and clinical predictors of low bone density and fracture risk in 77 patients with LDS type 1 to type 5. Results: Patients with LDS had dual-energy x-ray absorptiometry (DXA) Z-scores significantly < 0, and 50% of children and 9% of adults had Z-scores < –2. Sixty percent of patients had ≥1 fracture, and 24% of patients with spinal x-rays scans showed spinal compression fractures. Lower body mass index, asthma, male sex and eosinophilic gastrointestinal disease were correlated with lower DXA Z-scores. The count of 5 LDS-associated skeletal features (scoliosis, pes planus, arachnodactyly, spondylolisthesis, and camptodactyly) in patients with LDS was correlated with DXA Z-score. Adults with ≥1 skeletal features had DXA Z-scores significantly < 0, and children with >2 features had DXA Z-score significantly < –2. Bone turnover markers suggest accelerated bone resorption. Data from 5 patients treated with bisphosphonates suggest a beneficial effect. Conclusion: All LDS types are associated with reduced bone density and increased risk of fracture, which may be due to increased bone resorption. Clinical features can predict a subgroup of patients at highest risk of low bone density and fracture risk.
KW - Bone density
KW - DXA
KW - Fracture risk
KW - TGFβ
UR - http://www.scopus.com/inward/record.url?scp=85122953446&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122953446&partnerID=8YFLogxK
U2 - 10.1016/j.gim.2021.10.002
DO - 10.1016/j.gim.2021.10.002
M3 - Article
C2 - 34906513
AN - SCOPUS:85122953446
SN - 1098-3600
VL - 24
SP - 419
EP - 429
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 2
ER -